Archives for December 2020

Alira Health announces it’s role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy

Alira Health is pleased to announce its role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture [...]

Alira Health Welcomes Daniela Sica, Vice President of Business Development, Pharma and Biotech

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Daniela Sica has joined the firm as Vice [...]

Alira Health announced its role as strategic advisor to Mérieux Equity Partners and Mérieux Participations 3 for entering the capital of CTRS

Alira Health announced its role as strategic advisor to Merieux Equity Partners and Mérieux Participations 3 for entering the capital of CTRS, a French pharmaceutical company specialized in the [...]

Critical Success Factors in Market Access

Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product. Alira Health’s Richard Charter, VP MedTech Market Access Europe and [...]

Reduce Time to Market With Pre-IND Meetings

Did you know reducing time to market is one of the biggest challenges companies face when seeking FDA approval on their drug development plans and clinical trials? Olga Carroll, Alira Health’s [...]